Pathological Insights into the Subclassification of Diffuse Large B-Cell Lymphoma (NOS)

Abstract Introduction Diffuse Large B-cell Lymphoma, NOS represents around 25-35% of adult Non- Hodgkin’s lymphoma worldwide. According to the 5th edition of WHO for Hematolymphoid neoplasms, DLBCL, NOS encompasses all biologically heterogeneous cases with no clear criteria for inclusion in a specif...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:QJM : An International Journal of Medicine 2024-10, Vol.117 (Supplement_2)
Hauptverfasser: Girgis Boctor, Mary Louis Labib, Salman, Manal Ibrahim, Mohamed Abd El Khalek, Safaa Mahmoud, Halim Ibrahim, Mariam Ibrahim
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_2
container_start_page
container_title QJM : An International Journal of Medicine
container_volume 117
creator Girgis Boctor, Mary Louis Labib
Salman, Manal Ibrahim
Mohamed Abd El Khalek, Safaa Mahmoud
Halim Ibrahim, Mariam Ibrahim
description Abstract Introduction Diffuse Large B-cell Lymphoma, NOS represents around 25-35% of adult Non- Hodgkin’s lymphoma worldwide. According to the 5th edition of WHO for Hematolymphoid neoplasms, DLBCL, NOS encompasses all biologically heterogeneous cases with no clear criteria for inclusion in a specific diagnostic category. The sixth and seventh decade are reported as the median age for DLBCL, NOS in developed countries and a lower median age in developing countries, with slight male predominance (1.2:1). DLBCL, NOS is further subclassified according to cell of origin (COO) using gene expression profiling (GEP) and various immunohistocehmical (IHC) algorithms into germinal center (GCB) and activated B-cell (ABC) subtypes, which carries a prognostic and therapeutic value. Objectives In our study, we have recorded and compared the demographic and pathological data of the DLBCL, NOS subtypes in Ain Shams University Hospitals over the period of three years. Materials and Methods Our retrospective study was conducted in the Department of Histopathology in Ain Shams University Hospitals from January 2020 till December 2022. We retrieved all available cases with a diagnosis consistent with DLBCL, NOS over the period of these three years. A total of 102 cases with available reports, H&E slides and paraffin blocks with sufficient tissue material were included in this study. We recorded the demographic and pathological data of the cases, re-examined available H& E and IHC slides, and applied immunohistochemical (IHC) staining of CD10, and multiple myeloma oncogene 1(MUM1) to remaining DLBCL cases with available paraffin blocks and sufficient tissue material for further subclassification of into GCB and ABC subtypes according to the Hans and modified Hans immuoalgorithms. Finally, we compared and analyzed the demographic and pathological data of both subtypes. Results DLBCL, NOS represented 35.3 % of all NHL cases and 26.19% of all lymphoma cases overall. Out of 102 cases of DLBCL, NOS, 38.2% were GCB while were 61.8 % ABC subtypes. The median age for DLBCL, NOS was 54.9 with male to female ratio of 1.3:1. The ABC subtype showed a higher median age and female affection predominance as compared to GCB. The most affected site overall was the cervical nodal group while stomach, spleen and liver were reported as the most commonly involved extranodal sites. The ABC subtype showed significant association with extra-abdominal nodal groups as compared to the GCB subtype (P = 0
doi_str_mv 10.1093/qjmed/hcae175.714
format Article
fullrecord <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_qjmed_hcae175_714</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/qjmed/hcae175.714</oup_id><sourcerecordid>10.1093/qjmed/hcae175.714</sourcerecordid><originalsourceid>FETCH-LOGICAL-c794-e60adfcf3a93b55f0d89cc85445a8ba677dfe8ad31b6449453a6e46f04b3e3a03</originalsourceid><addsrcrecordid>eNqNkL1OwzAYRS0EEqXwAGweQSKtXdtxMkLLT6WIIrUSY_TFsRNXSRziZOjbE2jZme4d7rnDQeiWkhklMZt_7Wudz0sFmkoxk5SfoQnlIQkWLGbnf10uxCW68n5PCOGSRxP0-QF96SpXWAUVXjfeFmXvsW16h_tS4-2QqQq8t2Yc9NY12Bm8ssYMXuMEukLjp2Cpqwonh7otXQ347n2zvb9GFwYqr29OOUW7l-fd8i1INq_r5WMSKBnzQIcEcqMMg5hlQhiSR7FSkeBcQJRBKGVudAQ5o1nIecwFg1Dz0BCeMc2AsCmix1vVOe87bdK2szV0h5SS9EdM-ismPYlJRzEj83Bk3ND-Y_4NKXloJA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pathological Insights into the Subclassification of Diffuse Large B-Cell Lymphoma (NOS)</title><source>Oxford Journals</source><creator>Girgis Boctor, Mary Louis Labib ; Salman, Manal Ibrahim ; Mohamed Abd El Khalek, Safaa Mahmoud ; Halim Ibrahim, Mariam Ibrahim</creator><creatorcontrib>Girgis Boctor, Mary Louis Labib ; Salman, Manal Ibrahim ; Mohamed Abd El Khalek, Safaa Mahmoud ; Halim Ibrahim, Mariam Ibrahim</creatorcontrib><description>Abstract Introduction Diffuse Large B-cell Lymphoma, NOS represents around 25-35% of adult Non- Hodgkin’s lymphoma worldwide. According to the 5th edition of WHO for Hematolymphoid neoplasms, DLBCL, NOS encompasses all biologically heterogeneous cases with no clear criteria for inclusion in a specific diagnostic category. The sixth and seventh decade are reported as the median age for DLBCL, NOS in developed countries and a lower median age in developing countries, with slight male predominance (1.2:1). DLBCL, NOS is further subclassified according to cell of origin (COO) using gene expression profiling (GEP) and various immunohistocehmical (IHC) algorithms into germinal center (GCB) and activated B-cell (ABC) subtypes, which carries a prognostic and therapeutic value. Objectives In our study, we have recorded and compared the demographic and pathological data of the DLBCL, NOS subtypes in Ain Shams University Hospitals over the period of three years. Materials and Methods Our retrospective study was conducted in the Department of Histopathology in Ain Shams University Hospitals from January 2020 till December 2022. We retrieved all available cases with a diagnosis consistent with DLBCL, NOS over the period of these three years. A total of 102 cases with available reports, H&amp;E slides and paraffin blocks with sufficient tissue material were included in this study. We recorded the demographic and pathological data of the cases, re-examined available H&amp; E and IHC slides, and applied immunohistochemical (IHC) staining of CD10, and multiple myeloma oncogene 1(MUM1) to remaining DLBCL cases with available paraffin blocks and sufficient tissue material for further subclassification of into GCB and ABC subtypes according to the Hans and modified Hans immuoalgorithms. Finally, we compared and analyzed the demographic and pathological data of both subtypes. Results DLBCL, NOS represented 35.3 % of all NHL cases and 26.19% of all lymphoma cases overall. Out of 102 cases of DLBCL, NOS, 38.2% were GCB while were 61.8 % ABC subtypes. The median age for DLBCL, NOS was 54.9 with male to female ratio of 1.3:1. The ABC subtype showed a higher median age and female affection predominance as compared to GCB. The most affected site overall was the cervical nodal group while stomach, spleen and liver were reported as the most commonly involved extranodal sites. The ABC subtype showed significant association with extra-abdominal nodal groups as compared to the GCB subtype (P = 0.02). The mean Ki-67 proliferation index for DLBCL, NOS was 70.42% while the ABC subtype exhibited higher Ki-67 index with a mean of 74.21 as compared to the GCB subtype with a mean of 69.1 (P = 0.08). A higher proportion of cases of the ABC subtype exhibited &gt;70 % ki-67 proliferation index than the GCB subtype (P = 0.08). Tumor necrosis was noted in 34.8% of cases overall, with higher proportion of cases belonging to the ABC subtype (P = 0.45). Moreover, centroblastic morphological variant was the most common histology reported in both subtypes with less common histological features/variants observed in the ABC subtype; immunoblastic and anaplastic variants. Conclusion In conclusion, incidence of DLBCL, NOS in Ain Shams university hospitals was closely similar to recorded international incidence. According to COO, the ABC subtype was more frequent than the GCB subtype. The ABC subtype was associated with more nodal involvement with a significant predilection to extra- abdominal nodal groups. Moreover, the ABC subtype reported higher overall ki-67 proliferation index with more proportion of cases with &gt; 70% proliferation index and more advanced histological features: immunoblastic/anaplastic variants and necrosis.</description><identifier>ISSN: 1460-2725</identifier><identifier>EISSN: 1460-2393</identifier><identifier>DOI: 10.1093/qjmed/hcae175.714</identifier><language>eng</language><publisher>Oxford University Press</publisher><ispartof>QJM : An International Journal of Medicine, 2024-10, Vol.117 (Supplement_2)</ispartof><rights>The Author(s) 2024. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For permissions, please Email: journals.permissions@oup.com 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Girgis Boctor, Mary Louis Labib</creatorcontrib><creatorcontrib>Salman, Manal Ibrahim</creatorcontrib><creatorcontrib>Mohamed Abd El Khalek, Safaa Mahmoud</creatorcontrib><creatorcontrib>Halim Ibrahim, Mariam Ibrahim</creatorcontrib><title>Pathological Insights into the Subclassification of Diffuse Large B-Cell Lymphoma (NOS)</title><title>QJM : An International Journal of Medicine</title><description>Abstract Introduction Diffuse Large B-cell Lymphoma, NOS represents around 25-35% of adult Non- Hodgkin’s lymphoma worldwide. According to the 5th edition of WHO for Hematolymphoid neoplasms, DLBCL, NOS encompasses all biologically heterogeneous cases with no clear criteria for inclusion in a specific diagnostic category. The sixth and seventh decade are reported as the median age for DLBCL, NOS in developed countries and a lower median age in developing countries, with slight male predominance (1.2:1). DLBCL, NOS is further subclassified according to cell of origin (COO) using gene expression profiling (GEP) and various immunohistocehmical (IHC) algorithms into germinal center (GCB) and activated B-cell (ABC) subtypes, which carries a prognostic and therapeutic value. Objectives In our study, we have recorded and compared the demographic and pathological data of the DLBCL, NOS subtypes in Ain Shams University Hospitals over the period of three years. Materials and Methods Our retrospective study was conducted in the Department of Histopathology in Ain Shams University Hospitals from January 2020 till December 2022. We retrieved all available cases with a diagnosis consistent with DLBCL, NOS over the period of these three years. A total of 102 cases with available reports, H&amp;E slides and paraffin blocks with sufficient tissue material were included in this study. We recorded the demographic and pathological data of the cases, re-examined available H&amp; E and IHC slides, and applied immunohistochemical (IHC) staining of CD10, and multiple myeloma oncogene 1(MUM1) to remaining DLBCL cases with available paraffin blocks and sufficient tissue material for further subclassification of into GCB and ABC subtypes according to the Hans and modified Hans immuoalgorithms. Finally, we compared and analyzed the demographic and pathological data of both subtypes. Results DLBCL, NOS represented 35.3 % of all NHL cases and 26.19% of all lymphoma cases overall. Out of 102 cases of DLBCL, NOS, 38.2% were GCB while were 61.8 % ABC subtypes. The median age for DLBCL, NOS was 54.9 with male to female ratio of 1.3:1. The ABC subtype showed a higher median age and female affection predominance as compared to GCB. The most affected site overall was the cervical nodal group while stomach, spleen and liver were reported as the most commonly involved extranodal sites. The ABC subtype showed significant association with extra-abdominal nodal groups as compared to the GCB subtype (P = 0.02). The mean Ki-67 proliferation index for DLBCL, NOS was 70.42% while the ABC subtype exhibited higher Ki-67 index with a mean of 74.21 as compared to the GCB subtype with a mean of 69.1 (P = 0.08). A higher proportion of cases of the ABC subtype exhibited &gt;70 % ki-67 proliferation index than the GCB subtype (P = 0.08). Tumor necrosis was noted in 34.8% of cases overall, with higher proportion of cases belonging to the ABC subtype (P = 0.45). Moreover, centroblastic morphological variant was the most common histology reported in both subtypes with less common histological features/variants observed in the ABC subtype; immunoblastic and anaplastic variants. Conclusion In conclusion, incidence of DLBCL, NOS in Ain Shams university hospitals was closely similar to recorded international incidence. According to COO, the ABC subtype was more frequent than the GCB subtype. The ABC subtype was associated with more nodal involvement with a significant predilection to extra- abdominal nodal groups. Moreover, the ABC subtype reported higher overall ki-67 proliferation index with more proportion of cases with &gt; 70% proliferation index and more advanced histological features: immunoblastic/anaplastic variants and necrosis.</description><issn>1460-2725</issn><issn>1460-2393</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqNkL1OwzAYRS0EEqXwAGweQSKtXdtxMkLLT6WIIrUSY_TFsRNXSRziZOjbE2jZme4d7rnDQeiWkhklMZt_7Wudz0sFmkoxk5SfoQnlIQkWLGbnf10uxCW68n5PCOGSRxP0-QF96SpXWAUVXjfeFmXvsW16h_tS4-2QqQq8t2Yc9NY12Bm8ssYMXuMEukLjp2Cpqwonh7otXQ347n2zvb9GFwYqr29OOUW7l-fd8i1INq_r5WMSKBnzQIcEcqMMg5hlQhiSR7FSkeBcQJRBKGVudAQ5o1nIecwFg1Dz0BCeMc2AsCmix1vVOe87bdK2szV0h5SS9EdM-ismPYlJRzEj83Bk3ND-Y_4NKXloJA</recordid><startdate>20241001</startdate><enddate>20241001</enddate><creator>Girgis Boctor, Mary Louis Labib</creator><creator>Salman, Manal Ibrahim</creator><creator>Mohamed Abd El Khalek, Safaa Mahmoud</creator><creator>Halim Ibrahim, Mariam Ibrahim</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20241001</creationdate><title>Pathological Insights into the Subclassification of Diffuse Large B-Cell Lymphoma (NOS)</title><author>Girgis Boctor, Mary Louis Labib ; Salman, Manal Ibrahim ; Mohamed Abd El Khalek, Safaa Mahmoud ; Halim Ibrahim, Mariam Ibrahim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c794-e60adfcf3a93b55f0d89cc85445a8ba677dfe8ad31b6449453a6e46f04b3e3a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Girgis Boctor, Mary Louis Labib</creatorcontrib><creatorcontrib>Salman, Manal Ibrahim</creatorcontrib><creatorcontrib>Mohamed Abd El Khalek, Safaa Mahmoud</creatorcontrib><creatorcontrib>Halim Ibrahim, Mariam Ibrahim</creatorcontrib><collection>CrossRef</collection><jtitle>QJM : An International Journal of Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Girgis Boctor, Mary Louis Labib</au><au>Salman, Manal Ibrahim</au><au>Mohamed Abd El Khalek, Safaa Mahmoud</au><au>Halim Ibrahim, Mariam Ibrahim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pathological Insights into the Subclassification of Diffuse Large B-Cell Lymphoma (NOS)</atitle><jtitle>QJM : An International Journal of Medicine</jtitle><date>2024-10-01</date><risdate>2024</risdate><volume>117</volume><issue>Supplement_2</issue><issn>1460-2725</issn><eissn>1460-2393</eissn><abstract>Abstract Introduction Diffuse Large B-cell Lymphoma, NOS represents around 25-35% of adult Non- Hodgkin’s lymphoma worldwide. According to the 5th edition of WHO for Hematolymphoid neoplasms, DLBCL, NOS encompasses all biologically heterogeneous cases with no clear criteria for inclusion in a specific diagnostic category. The sixth and seventh decade are reported as the median age for DLBCL, NOS in developed countries and a lower median age in developing countries, with slight male predominance (1.2:1). DLBCL, NOS is further subclassified according to cell of origin (COO) using gene expression profiling (GEP) and various immunohistocehmical (IHC) algorithms into germinal center (GCB) and activated B-cell (ABC) subtypes, which carries a prognostic and therapeutic value. Objectives In our study, we have recorded and compared the demographic and pathological data of the DLBCL, NOS subtypes in Ain Shams University Hospitals over the period of three years. Materials and Methods Our retrospective study was conducted in the Department of Histopathology in Ain Shams University Hospitals from January 2020 till December 2022. We retrieved all available cases with a diagnosis consistent with DLBCL, NOS over the period of these three years. A total of 102 cases with available reports, H&amp;E slides and paraffin blocks with sufficient tissue material were included in this study. We recorded the demographic and pathological data of the cases, re-examined available H&amp; E and IHC slides, and applied immunohistochemical (IHC) staining of CD10, and multiple myeloma oncogene 1(MUM1) to remaining DLBCL cases with available paraffin blocks and sufficient tissue material for further subclassification of into GCB and ABC subtypes according to the Hans and modified Hans immuoalgorithms. Finally, we compared and analyzed the demographic and pathological data of both subtypes. Results DLBCL, NOS represented 35.3 % of all NHL cases and 26.19% of all lymphoma cases overall. Out of 102 cases of DLBCL, NOS, 38.2% were GCB while were 61.8 % ABC subtypes. The median age for DLBCL, NOS was 54.9 with male to female ratio of 1.3:1. The ABC subtype showed a higher median age and female affection predominance as compared to GCB. The most affected site overall was the cervical nodal group while stomach, spleen and liver were reported as the most commonly involved extranodal sites. The ABC subtype showed significant association with extra-abdominal nodal groups as compared to the GCB subtype (P = 0.02). The mean Ki-67 proliferation index for DLBCL, NOS was 70.42% while the ABC subtype exhibited higher Ki-67 index with a mean of 74.21 as compared to the GCB subtype with a mean of 69.1 (P = 0.08). A higher proportion of cases of the ABC subtype exhibited &gt;70 % ki-67 proliferation index than the GCB subtype (P = 0.08). Tumor necrosis was noted in 34.8% of cases overall, with higher proportion of cases belonging to the ABC subtype (P = 0.45). Moreover, centroblastic morphological variant was the most common histology reported in both subtypes with less common histological features/variants observed in the ABC subtype; immunoblastic and anaplastic variants. Conclusion In conclusion, incidence of DLBCL, NOS in Ain Shams university hospitals was closely similar to recorded international incidence. According to COO, the ABC subtype was more frequent than the GCB subtype. The ABC subtype was associated with more nodal involvement with a significant predilection to extra- abdominal nodal groups. Moreover, the ABC subtype reported higher overall ki-67 proliferation index with more proportion of cases with &gt; 70% proliferation index and more advanced histological features: immunoblastic/anaplastic variants and necrosis.</abstract><pub>Oxford University Press</pub><doi>10.1093/qjmed/hcae175.714</doi></addata></record>
fulltext fulltext
identifier ISSN: 1460-2725
ispartof QJM : An International Journal of Medicine, 2024-10, Vol.117 (Supplement_2)
issn 1460-2725
1460-2393
language eng
recordid cdi_crossref_primary_10_1093_qjmed_hcae175_714
source Oxford Journals
title Pathological Insights into the Subclassification of Diffuse Large B-Cell Lymphoma (NOS)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T16%3A53%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pathological%20Insights%20into%20the%20Subclassification%20of%20Diffuse%20Large%20B-Cell%20Lymphoma%20(NOS)&rft.jtitle=QJM%20:%20An%20International%20Journal%20of%20Medicine&rft.au=Girgis%20Boctor,%20Mary%20Louis%20Labib&rft.date=2024-10-01&rft.volume=117&rft.issue=Supplement_2&rft.issn=1460-2725&rft.eissn=1460-2393&rft_id=info:doi/10.1093/qjmed/hcae175.714&rft_dat=%3Coup_cross%3E10.1093/qjmed/hcae175.714%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/qjmed/hcae175.714&rfr_iscdi=true